Controlled Substances
Framework
Kentucky adopts the federal schedules in KRS Chapter 218A and adds state restrictions; where state rules are stricter, follow the state. DEA registration is required for each location handling controlled substances, and it cannot exist without the state credential.
Core compliance rules
Schedule II: no refills; written or electronic prescriptions; an emergency oral order must be followed by a written prescription within the federal short window. Recordkeeping: biennial inventory, records maintained and retrievable for the required retention period, power of attorney for DEA Form 222, CSOS for electronic orders. Theft or significant loss must be reported to DEA on a DEA Form 106 within one business day of discovery, with Board notification as well. Destruction goes through a reverse distributor or witnessed destruction with documentation.
Kentucky-specific watch items
KASPER (Kentucky All Schedule Prescription Electronic Reporting) is the state monitoring program. Dispensers report each controlled-substance dispensing within one business day, and prescribers must review KASPER in defined circumstances. Kentucky has also placed gabapentin in Schedule V, so a “non-controlled” assumption about a neuropathy/seizure drug can be wrong here. Pseudoephedrine sales are quantity-limited and tracked through an electronic logging system with photo ID.
Traps: assuming the federal schedule is the whole answer; treating corresponding responsibility as the prescriber's problem alone; assuming one state's DEA registration covers a pharmacy in another; assuming partial fills are always forbidden.
Rule of thumb: “Two years of records, one inventory every two years, one business day to report a loss.”